Explore more publications!

Technology Digest Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.

Press releases published on April 30, 2026

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
TransAlta Corporation Announces Results of the 2026 Annual and Special Meeting of Shareholders and Election of all Directors
Svitla Systems Acquires Australia’s Kiandra IT to Expand Global Engineering Footprint and Accelerate AI-Driven Delivery
Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026
TLX101-Px (Pixlumi®) MAA Accepted in Europe
TTEC Recognized as a Major Contender in Everest Group’s 2026 Healthcare CXM Intelligent Operations PEAK Matrix® Assessment
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
Inventronics Announces 2026 Q1 Financial Results
Juvthorix Unveiled: Should You Join Juvthorix? Hidden Features, Performance, Fees & Real User Insights!
WISeKey Reports Audited Full Year 2025 Financial Results
reAlpha (NASDAQ: AIRE) Announces AiChat Launch of Shopify Conversational Commerce Integration and AI Ticketing for eCommerce
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
DBV Technologies Reports First Quarter 2026 Financial Results
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
Alvotech Announces a Change in its Executive Team
Cue Biopharma Announces $30 Million Private Placement
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions